FC
ATHE

FIC Capital’s Alterity Therapeutics ATHE Stock Holding History

FIC Capital’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,268
Closed -$533K – 139
2013
Q4 		$533K Sell
1,268
-5
-0.4% -$1.5K 0.24% 115
2013
Q3 		$314K Buy
1,273
+413
+48% +$94.8K 0.16% 128
2013
Q2 		$120K Buy
+860
New +$117K 0.08% 128

Other funds holding ATHE

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CAM
Columbia Asset Management Ann Arbor, Michigan $525M AUM 21.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FIC Capital's ATHE Position: Q1 2014 in Review

FIC Capital sold out of Alterity Therapeutics (ATHE) in Q1 2014, closing a stake of 1,268 shares — an estimated $533K sold.

FIC Capital first reported a position in ATHE in Q2 2013 and held it in 3 quarters. The position peaked at $533K in Q4 2013. 29 funds tracked by Wall St. Rank hold ATHE as of Q1 2014.

  • FIC Capital reported no remaining Alterity Therapeutics position as of Q1 2014 after selling out during the quarter.
  • FIC Capital sold 1,268 Alterity Therapeutics shares in Q1 2014, an estimated $533K.
  • FIC Capital first reported a position in Alterity Therapeutics in Q2 2013 and held it in 3 quarters.
  • FIC Capital's Alterity Therapeutics position peaked at $533K in Q4 2013.
  • 29 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q1 2014.

Based on FIC Capital's 13F filing for Q1 2014, filed 14 May 2014.